Food for Thought 2001: Quality Control of Supplement G. Douglas Andersen, DC, DACBSP, CCN Volume
19, number 4, 2/12/01, page 30 At the same time,
the spotlight of acceptance for nutritional supplements continues to brighten,
a malignancy driven by greed and fueled by freedom (i.e., minimal regulation)
is spreading like wildfire. The problem I am speaking of is quality control.
When a patient states that a certain supplement did not help, I always
wonder if he or she was actually taking a pure, bioavailable product.
Off-the-Shelf Studies With the growing popularity of a wide variety of supplements and the impressive science behind them, consumer groups, the media and university scientists have begun to test nutritional products at an ever-increasing rate. An off-the-shelf supplement analysis study is exactly how it sounds. That is, researchers buy products off the same shelves as consumers, then test them to see if they meet label claims and how accurate these claims are The studies do not test for bioavailability, which is another equally important (if not more important) issue. Furthermore, most products sold are marketed based on positive human trials. What the ads don't say is that the supplements in studies are pure, potent, bioactive and bio-available. As we will see, the same does not necessarily hold true for what your patients are able to purchase on a retail level. In a recent issue of the University of California Berkeley Wellness Letter,1(http://www.berkeleywellness.com) the editors mentioned a recent saw palmetto investigation in which only 17 of 27 products met label claims. Last month we discussed that only five of 32 brands of chondroitin sulfate tested achieved label claims.2 Iincluded in the article are the findings of two recent off-the-shelf analyses. Please note that cost does not guarantee a better product. Although herbals seem to have the most problems, vitamins and minerals are not immune. Consumerlabs.com, a privately financed testing company, found that four out of 26 vitamin C products did not meet label claims. In a large study of 136 brands of calcium supplement, two thirds exceeded 1.5 mcg of lead per serving.3
In August 1998, The L.A. Times bought nine
brands of St. John's wort and took them to an independent laboratory.
Flora Research of San Juan Capistrano tested the products. The potency
was the average of three samples. Notice the wide range of values versus
what the labels claimed. Hypercin is a key active compound. Source: Los
Angeles Times, August 31, 1998. It is this author's opinion that the burden of proof falls on all supplement companies and their marketers to prove that what they are selling meets both the label requirements and is bioactive. This should include full-disclosure labels; realistic dosing instructions, possible side effects; product expiration date; storage directions, and what to do if the products are exposed to unfavorable conditions. References
916
E. Imperial Hwy. gdandersen@earthlink.net
|